Ackman Welcomes SEC Probe As IRS Targets Valeant – ValueWalk Premium
CREW Herbalife Ltd. HLF Bill Ackman speaking

Ackman Welcomes SEC Probe As IRS Targets Valeant

Bill Ackman welcomes a Securities and Exchange investigation into Pershing Square Capital Management LP and its involvement with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) in the hostile takeover bid of Allergan, Inc. (NYSE:AGN).

Ackmanstands by his action
Ackman says there was nothing wrong with the tactics and . . .


This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email or click Chat.

Saved Articles
Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds.   

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.